News • Research project

Can new molecular imaging technology guide prostate cancer surgery?

Operation chamber
Complete removal of malignant tissue during prostate cancer surgery can be challenging, especially in later-stage disease, as it can be difficult to distinguish between cancerous and non-cancerous tissue.
Source: pixabay

The Netherlands Cancer Institute (NKI) announced that it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery. The project will evaluate the imaging technology’s ability to detect prostate cancer during surgery, with the aim of performing more accurate removal of cancerous tissue.

Prostate cancer is the most common cancer among men in Europe with over 350,000 diagnosed in Europe every year. Complete removal of malignant tissue during prostate cancer surgery can be challenging, especially in later-stage disease, as it can be difficult to distinguish between cancerous and non-cancerous tissue. Accordingly, there is a crucial need for new technologies to help surgeons visualize cancer in real time during an operation to ensure that the cancer has been completely removed.

If this technique is successful, we will be able to guide the urologist in the most optimal way by combining pre-operative staging with per-operative imaging using the same tracer.

Dr Marcel Stokkel

In the joint research project, the Netherlands Cancer Institute, University of Twente and industry partners, Lightpoint Medical and Philips will evaluate a novel molecular imaging technology to image the prostate cancer biomarker Prostate Specific Membrane Antigen (PSMA) during surgery. If successful, the technology will be tested in larger clinical trials with the aim of sparing healthy tissue and reducing recurrence rates in prostate cancer surgery.

Dr Marcel Stokkel, Nuclear Medicine Physician at NKI, commented, “If this technique is successful, we will be able to guide the urologist in the most optimal way by combining pre-operative staging with per-operative imaging using the same tracer. If the resection margins can be assessed with highest accuracy during surgery, we might become able to improve recurrence and survival rates. The collaboration with Lightpoint Medical, Philips and the University of Twente is the most optimal setting to reach this goal and to complete this study.”

“We are delighted to embark on this collaboration with the NKI and Philips. Intraoperative molecular imaging holds enormous potential in prostate cancer surgery. This project will bring the technology a step closer to the patients in need of better treatment options” commented Dr David Tuch, CEO of Lightpoint Medical.


Source: Netherlands Cancer Institute

17.10.2017

Read all latest stories

Related articles

Photo

News • Imaging

PSMA PET/CT beats standard scan at prostate cancer detecting

Prostate-specific membrane antigen imaging should be the positron emission tomography imaging agent of choice for men who have a prostate cancer recurrence after radical prostatectomy, which needs to…

Photo

News • Research

Prostate cancer: Researchers find molecular switch to prolong survival

Wilmot Cancer Institute scientists believe they have figured out why a commonly used drug to treat late-stage prostate cancer often stops working after four or five months and appears to have a dual…

Photo

News • Pathology test

AI predicts prostate cancer progression following surgery

A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following surgery,…

Related products

Canon Electron Tubes & Devices – X-ray Image Intensifier

Accessories / Complementary Systems

Canon Electron Tubes & Devices – X-ray Image Intensifier

Canon Electron Tubes & Devices Co., Ltd
DK Medical – Prostar

Surgical II-C-Arms

DK Medical – Prostar

DK Medical Systems Co., Ltd
Fujifilm - FDX Visionary-C and CS

Surgical Flat Panel C-arms

Fujifilm - FDX Visionary-C and CS

FUJIFILM Europe GmbH
Fujifilm – Synapse 3D

Reading

Fujifilm – Synapse 3D

FUJIFILM Europe GmbH
GMM – Symbol FP – Mobile C-Arm system

Surgical Flat Panel C-Arms

GMM – Symbol FP – Mobile C-Arm system

General Medical Merate S.p.A. (GMM Group)
Intermedical – "New" Radius

Surgical II-C-Arms

Intermedical – "New" Radius

INTERMEDICAL SRL
Subscribe to Newsletter